Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks.
This report contains market size and forecasts of Sinusitis Medicine in Global, including the following market information:
Global Sinusitis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sinusitis Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sinusitis Medicine include Sanofi, Bayer, Pfizer, AstraZeneca, Novartis, Johnson & Johnson, Merck, Amgen and Bionorica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sinusitis Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sinusitis Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sinusitis Medicine Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Corticosteroids
Decongestants
Other
Global Sinusitis Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sinusitis Medicine Market Segment Percentages, by Application, 2021 (%)
Acute Sinusitis
Chronic Sinusitis
Global Sinusitis Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sinusitis Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sinusitis Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sinusitis Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bayer
Pfizer
AstraZeneca
Novartis
Johnson & Johnson
Merck
Amgen
Bionorica
Dr. Reddy's Laboratories
Huasun